Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
Physiol Res ; 73(1): 27-35, 2024 03 11.
Article En | MEDLINE | ID: mdl-38466002

Angiotensin-converting enzyme 2 (ACE2), one of the key enzymes of the renin-angiotensin system (RAS), plays an important role in SARS-CoV-2 infection by functioning as a virus receptor. Angiotensin peptides Ang I and Ang II, the substrates of ACE2, can modulate the binding of SARS-CoV-2 Spike protein to the ACE2 receptor. In the present work, we found that co incubation of HEK-ACE2 and Vero E6 cells with the SARS-CoV-2 Spike pseudovirus (PVP) resulted in stimulation of the virus entry at low and high micromolar concentrations of Ang I and Ang II, respectively. The potency of Ang I and Ang II stimulation of virus entry corresponds to their binding affinity to ACE2 catalytic pocket with 10 times higher efficiency of Ang II. The Ang II induced mild increase of PVP infectivity at 20 microM; while at 100 microM the increase (129.74+/-3.99 %) was highly significant (p<0.001). Since the angiotensin peptides act in HEK ACE2 cells without the involvement of angiotensin type I receptors, we hypothesize that there is a steric interaction between the catalytic pocket of the ACE2 enzyme and the SARS-CoV-2 S1 binding domain. Oversaturation of the ACE2 with their angiotensin substrate might result in increased binding and entry of the SARS-CoV-2. In addition, the analysis of angiotensin peptides metabolism showed decreased ACE2 and increased ACE activity upon SARS-CoV-2 action. These effects should be taken into consideration in COVID-19 patients suffering from comorbidities such as the over-activated renin-angiotensin system as a mechanism potentially influencing the SARS-CoV-2 invasion into recipient cells.


COVID-19 , Renin-Angiotensin System , Spike Glycoprotein, Coronavirus , Humans , SARS-CoV-2/metabolism , Angiotensin-Converting Enzyme 2/metabolism , Angiotensin I/metabolism , Angiotensin I/pharmacology , Peptidyl-Dipeptidase A/metabolism , Angiotensin-Converting Enzyme Inhibitors , Angiotensin II/metabolism
2.
Bratisl Lek Listy ; 107(9-10): 384-94, 2006.
Article En | MEDLINE | ID: mdl-17262991

Oxidative stress has been implicated in the pathogenesis of Alzheimer's disease (AD) as a relevant marker of neuronal degeneration. However it plays an important role not only in the pathogenesis of neurodegenerative diseases but also in other critical disorders like heart diseases, carcinogenesis and others. Oxidative stress is also associated with normal aging. In this review we discuss a crucial question: to what extent oxidative stress may be a causative factor in pathogenesis of AD type of neurodegeneration. The results of several recent epidemiological studies appeared to be controversial at this point. It is believed that antioxidant therapies may have beneficial effects at least in delaying disease progression and appearance of AD specific clinical symptoms. Since there is no cure for AD recently, healthy life style and antioxidants enriched nutrition (or even antioxidant therapy) may provide an effective way of fighting against this deleterious disease (Ref. 102).


Alzheimer Disease/metabolism , Oxidative Stress , Alzheimer Disease/drug therapy , Antioxidants/therapeutic use , Humans , Nerve Degeneration/metabolism
3.
Neoplasma ; 50(6): 403-7, 2003.
Article En | MEDLINE | ID: mdl-14689060

Germline mutations in the BRCA1 and BRCA2 genes are required for the initiation of the development of hereditary forms of breast and ovarian cancer, which represent 10-15% of all cases. The course of the disease varies from case to case that can be due even to the possibility of multiple genetic changes including inactivation of other tumor suppressor genes--TP53 and APC genes or activation of oncogenes, especially K-ras oncogene. The combination of these changes results in an early expression of the broad variety of malignancies. The analyzed proband (II-5) comes from a high-risk family, in which various types of cancer were observed. The novel BRCA1 mutation in exon 11 (2057delCAGTGAAGAG) was detected by SSCP, HDA techniques and confirmed by automatic sequencing. The same deletion was observed in DNA sample of her first daughter (III-1), but DNA of her second one was without any mutational changes (III-2). Due to the occurrence of different types of cancer in this family, the incidental mutations in the APC; resp. TP53 tumor supressor genes and K-ras oncogene were searched as well. Any mutation was found after sequencing of SSCP interesting exons of these genes. The reasons for such strong malignant manifestation in this high risk family are discussed.


Breast Neoplasms/genetics , Exons , Genes, BRCA1 , Mutation , Ovarian Neoplasms/genetics , Polymorphism, Single-Stranded Conformational , Sequence Deletion , Amino Acid Sequence , Base Sequence , Colonic Neoplasms/genetics , DNA Primers , Female , Genes, ras , Humans , Laryngeal Neoplasms/genetics , Male , Middle Aged , Pedigree , Polymerase Chain Reaction , Risk Assessment
...